# Recurrent Liver Cancer: Reconceptualization and Reevaluation

> **NCT06430983** · — · RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Recurrent Liver Cancer
- Primary Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06430983
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430983, "Recurrent Liver Cancer: Reconceptualization and Reevaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06430983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*